New cream for mild to moderate plaque psoriasis
Treatments studied
Part of Skin clinical trials.
This trial tests a new topical cream for people with mild or moderate plaque psoriasis. It aims to see if the cream can improve psoriasis patches on the skin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have mild or moderate plaque psoriasis, confirmed by a doctor's exam or dermoscopy.
- You must not have used any psoriasis treatments (creams, light therapy, or pills) in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.
This trial tests if adding metformin to secukinumab improves psoriasis in overweight or obese patients. If you have moderate-to-severe plaque psoriasis and a BMI of 25 or higher, this study may offer a new treatment option.
This trial tests an experimental pill called D-2570 for people with moderate to severe plaque psoriasis. It aims to see if the pill can safely improve skin symptoms like redness, scaling, and thickness.
This trial tests whether a cream containing metformin (a diabetes medication) can help reduce mild psoriasis patches on the skin. Researchers want to see if applying it directly to affected areas improves symptoms without needing pills or injections.
This trial tests an oral tablet (CMS-D001) for adults with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective in reducing psoriasis severity.
This study tests a new cream form of the drug apremilast for mild plaque psoriasis that covers no more than 10% of your body. It aims to see if the cream is safe and works well for treating small patches of psoriasis.
Hear when a new Plaque Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.